Diaceutics PLC
DXRX.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | £49,669 | £106,333 | £107,675 | £73,248 |
| - Cash | £10,384 | £12,744 | £16,749 | £16,667 |
| + Debt | £1,134 | £1,060 | £1,134 | £1,205 |
| Enterprise Value | £40,419 | £94,649 | £92,060 | £57,786 |
| Revenue | £14,564 | £19,838 | £12,320 | £13,775 |
| % Growth | -26.6% | 61% | -10.6% | – |
| Gross Profit | £12,087 | £17,539 | £8,613 | £11,006 |
| % Margin | 83% | 88.4% | 69.9% | 79.9% |
| EBITDA | -£1,341 | £4,035 | -£961 | £2,339 |
| % Margin | -9.2% | 20.3% | -7.8% | 17% |
| Net Income | -£2,401 | £881 | -£2,584 | -£261 |
| % Margin | -16.5% | 4.4% | -21% | -1.9% |
| EPS Diluted | -0.028 | 0.01 | -0.031 | -0.003 |
| % Growth | -373.1% | 134% | -887.1% | – |
| Operating Cash Flow | £605 | -£501 | £1,501 | £613 |
| Capital Expenditures | -£55 | -£39 | -£61 | -£64 |
| Free Cash Flow | £550 | -£540 | £1,440 | £549 |